Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice

J. D. Caldwell, G. A. Mason, D. A. Stanley, G. Jerdack, Victor J Hruby, P. Hill, A. J. Prange, C. A. Pedersen

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Several peptides, including arginine-vasopressin (AVP), neurotensin, and substance P, produce analgesia that is not mediated by opiate systems. Using the hot plate test, we studied the analgesic effects of intracisternal (i.c.) administration of various doses of the nonapeptide oxytocin (OXY) in Swiss-Webster mice. We found that OXY (1-4 μg) significantly increased the latency of animals to jump or lick their paws after placement on a hot plate. This effect was not blocked by naloxone pretreatment, which suggests that it is not opiate dependent. Using the hot plate test, we confirmed that AVP (1 and 4 μg) also produces analgesia. We then studied the analgesia produced by OXY and by AVP using 3 nonapeptide analogues with antagonist properties: [Pen1, LpMePhe2, Thr4, Orn8]OXY (PLMPTO-OXY) that has anti-oxytocic properties in the uterine contraction assay, d(CH2)5Tyr(Me)AVP (dTM-AVP) which antagonizes the antidiuretic properties of AVP and d(CH2)5d-Ile2,Abu4-AVP (dIA-AVP) which antagonizes the vasopressor effects of AVP. Simultaneous administration of PLMPTO-OXY completely blocked the analgesia produced by OXY whereas the antidiuretic antagonist dIA-AVP partially blocked OXY-induced analgesia and dTM-AVP had no effect. None of the antagonists used blocked AVP-induced analgesia. We concluded that the neural systems mediating the analgesic effects of i.c. OXY differ from those for AVP.

Original languageEnglish (US)
Pages (from-to)233-241
Number of pages9
JournalRegulatory Peptides
Volume18
Issue number3-4
DOIs
StatePublished - Aug 17 1987

Fingerprint

Arginine Vasopressin
Oxytocin
Analgesia
Opiate Alkaloids
Analgesics
Oxytocics
Uterine Contraction
Neurotensin
Substance P
Naloxone
Assays
Animals

Keywords

  • Analgesia
  • Antagonist
  • Intracisternal
  • Mouse
  • Oxytocin
  • Vasopressin

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Neuroscience(all)

Cite this

Caldwell, J. D., Mason, G. A., Stanley, D. A., Jerdack, G., Hruby, V. J., Hill, P., ... Pedersen, C. A. (1987). Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice. Regulatory Peptides, 18(3-4), 233-241. https://doi.org/10.1016/0167-0115(87)90011-5

Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice. / Caldwell, J. D.; Mason, G. A.; Stanley, D. A.; Jerdack, G.; Hruby, Victor J; Hill, P.; Prange, A. J.; Pedersen, C. A.

In: Regulatory Peptides, Vol. 18, No. 3-4, 17.08.1987, p. 233-241.

Research output: Contribution to journalArticle

Caldwell, JD, Mason, GA, Stanley, DA, Jerdack, G, Hruby, VJ, Hill, P, Prange, AJ & Pedersen, CA 1987, 'Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice', Regulatory Peptides, vol. 18, no. 3-4, pp. 233-241. https://doi.org/10.1016/0167-0115(87)90011-5
Caldwell, J. D. ; Mason, G. A. ; Stanley, D. A. ; Jerdack, G. ; Hruby, Victor J ; Hill, P. ; Prange, A. J. ; Pedersen, C. A. / Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice. In: Regulatory Peptides. 1987 ; Vol. 18, No. 3-4. pp. 233-241.
@article{54cae140aea84cfd909bed2bd4916176,
title = "Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice",
abstract = "Several peptides, including arginine-vasopressin (AVP), neurotensin, and substance P, produce analgesia that is not mediated by opiate systems. Using the hot plate test, we studied the analgesic effects of intracisternal (i.c.) administration of various doses of the nonapeptide oxytocin (OXY) in Swiss-Webster mice. We found that OXY (1-4 μg) significantly increased the latency of animals to jump or lick their paws after placement on a hot plate. This effect was not blocked by naloxone pretreatment, which suggests that it is not opiate dependent. Using the hot plate test, we confirmed that AVP (1 and 4 μg) also produces analgesia. We then studied the analgesia produced by OXY and by AVP using 3 nonapeptide analogues with antagonist properties: [Pen1, LpMePhe2, Thr4, Orn8]OXY (PLMPTO-OXY) that has anti-oxytocic properties in the uterine contraction assay, d(CH2)5Tyr(Me)AVP (dTM-AVP) which antagonizes the antidiuretic properties of AVP and d(CH2)5d-Ile2,Abu4-AVP (dIA-AVP) which antagonizes the vasopressor effects of AVP. Simultaneous administration of PLMPTO-OXY completely blocked the analgesia produced by OXY whereas the antidiuretic antagonist dIA-AVP partially blocked OXY-induced analgesia and dTM-AVP had no effect. None of the antagonists used blocked AVP-induced analgesia. We concluded that the neural systems mediating the analgesic effects of i.c. OXY differ from those for AVP.",
keywords = "Analgesia, Antagonist, Intracisternal, Mouse, Oxytocin, Vasopressin",
author = "Caldwell, {J. D.} and Mason, {G. A.} and Stanley, {D. A.} and G. Jerdack and Hruby, {Victor J} and P. Hill and Prange, {A. J.} and Pedersen, {C. A.}",
year = "1987",
month = "8",
day = "17",
doi = "10.1016/0167-0115(87)90011-5",
language = "English (US)",
volume = "18",
pages = "233--241",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "3-4",

}

TY - JOUR

T1 - Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice

AU - Caldwell, J. D.

AU - Mason, G. A.

AU - Stanley, D. A.

AU - Jerdack, G.

AU - Hruby, Victor J

AU - Hill, P.

AU - Prange, A. J.

AU - Pedersen, C. A.

PY - 1987/8/17

Y1 - 1987/8/17

N2 - Several peptides, including arginine-vasopressin (AVP), neurotensin, and substance P, produce analgesia that is not mediated by opiate systems. Using the hot plate test, we studied the analgesic effects of intracisternal (i.c.) administration of various doses of the nonapeptide oxytocin (OXY) in Swiss-Webster mice. We found that OXY (1-4 μg) significantly increased the latency of animals to jump or lick their paws after placement on a hot plate. This effect was not blocked by naloxone pretreatment, which suggests that it is not opiate dependent. Using the hot plate test, we confirmed that AVP (1 and 4 μg) also produces analgesia. We then studied the analgesia produced by OXY and by AVP using 3 nonapeptide analogues with antagonist properties: [Pen1, LpMePhe2, Thr4, Orn8]OXY (PLMPTO-OXY) that has anti-oxytocic properties in the uterine contraction assay, d(CH2)5Tyr(Me)AVP (dTM-AVP) which antagonizes the antidiuretic properties of AVP and d(CH2)5d-Ile2,Abu4-AVP (dIA-AVP) which antagonizes the vasopressor effects of AVP. Simultaneous administration of PLMPTO-OXY completely blocked the analgesia produced by OXY whereas the antidiuretic antagonist dIA-AVP partially blocked OXY-induced analgesia and dTM-AVP had no effect. None of the antagonists used blocked AVP-induced analgesia. We concluded that the neural systems mediating the analgesic effects of i.c. OXY differ from those for AVP.

AB - Several peptides, including arginine-vasopressin (AVP), neurotensin, and substance P, produce analgesia that is not mediated by opiate systems. Using the hot plate test, we studied the analgesic effects of intracisternal (i.c.) administration of various doses of the nonapeptide oxytocin (OXY) in Swiss-Webster mice. We found that OXY (1-4 μg) significantly increased the latency of animals to jump or lick their paws after placement on a hot plate. This effect was not blocked by naloxone pretreatment, which suggests that it is not opiate dependent. Using the hot plate test, we confirmed that AVP (1 and 4 μg) also produces analgesia. We then studied the analgesia produced by OXY and by AVP using 3 nonapeptide analogues with antagonist properties: [Pen1, LpMePhe2, Thr4, Orn8]OXY (PLMPTO-OXY) that has anti-oxytocic properties in the uterine contraction assay, d(CH2)5Tyr(Me)AVP (dTM-AVP) which antagonizes the antidiuretic properties of AVP and d(CH2)5d-Ile2,Abu4-AVP (dIA-AVP) which antagonizes the vasopressor effects of AVP. Simultaneous administration of PLMPTO-OXY completely blocked the analgesia produced by OXY whereas the antidiuretic antagonist dIA-AVP partially blocked OXY-induced analgesia and dTM-AVP had no effect. None of the antagonists used blocked AVP-induced analgesia. We concluded that the neural systems mediating the analgesic effects of i.c. OXY differ from those for AVP.

KW - Analgesia

KW - Antagonist

KW - Intracisternal

KW - Mouse

KW - Oxytocin

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0023230895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023230895&partnerID=8YFLogxK

U2 - 10.1016/0167-0115(87)90011-5

DO - 10.1016/0167-0115(87)90011-5

M3 - Article

C2 - 3671785

AN - SCOPUS:0023230895

VL - 18

SP - 233

EP - 241

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 3-4

ER -